1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2017


DelveInsight’s, “Cannabinoid Receptor Type 1 (CB1) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Receptor Type 1 (CB1) Antagonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cannabinoid Receptor Type 1 (CB1) Antagonists. DelveInsight’s Report also assesses the Cannabinoid Receptor Type 1 (CB1) Antagonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Cannabinoid Receptor Type 1 (CB1) Antagonists
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Cannabinoid Receptor Type 1 (CB1) Antagonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Cannabinoid Receptor Type 1 (CB1) Antagonists and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2017
Illustrative

- Cannabinoid Receptor Type 1 (CB1) Antagonists Overview
- Cannabinoid Receptor Type 1 (CB1) Antagonists Disease Associated
- Cannabinoid Receptor Type 1 (CB1) Antagonists Pipeline Therapeutics
- Cannabinoid Receptor Type 1 (CB1) Antagonists Therapeutics under Development by Companies
- Cannabinoid Receptor Type 1 (CB1) Antagonists Filed and Phase III Products
- Comparative Analysis
- Cannabinoid Receptor Type 1 (CB1) Antagonists Phase II Products
- Comparative Analysis
- Cannabinoid Receptor Type 1 (CB1) Antagonists Phase I and IND Filed Products
- Comparative Analysis
- Cannabinoid Receptor Type 1 (CB1) Antagonists Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Cannabinoid Receptor Type 1 (CB1) Antagonists - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Cannabinoid Receptor Type 1 (CB1) Antagonists - Discontinued Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists - Dormant Products
- Companies Involved in Therapeutics Development for Cannabinoid Receptor Type 1 (CB1) Antagonists
- Appendix
- Methodology
- Contact Us
- Disclaimer



List of Tables

- Number of Products under Development for Cannabinoid Receptor Type 1 (CB1) Antagonists by Therapy Area, 2017
- Number of Products under Development for Cannabinoid Receptor Type 1 (CB1) Antagonists, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Monotherapy Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Combination Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Route of Administration
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Stage and Route of Administration
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Molecule Type
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Stage and Molecule Type
- Cannabinoid Receptor Type 1 (CB1) Antagonists Therapeutics - Discontinued Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Cannabinoid Receptor Type 1 (CB1) Antagonists by Therapy Area, 2017
- Number of Products under Development for Cannabinoid Receptor Type 1 (CB1) Antagonists, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Monotherapy Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Combination Products
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Route of Administration
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Stage and Route of Administration
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Molecule Type
- Cannabinoid Receptor Type 1 (CB1) Antagonists Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Pain Management - Medical Devices Pipeline Assessment, 2016

Pain Management - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Pain Management - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2016" provides an overview of Pain ...

Global and Chinese Hydromorphone Hydrochloride (CAS 71-68-1) Industry, 2017 Market Research Report

Global and Chinese Hydromorphone Hydrochloride (CAS 71-68-1) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Hydromorphone Hydrochloride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Hydromorphone Hydrochloride industry ...

Global and Chinese Pain Management Table Industry, 2017 Market Research Report

Global and Chinese Pain Management Table Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The ’Global and Chinese Pain Management Table Industry, 2012-2022 Market Research Report’ is a professional and in-depth study on the current state of the global Pain Management Table industry with ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • February 2017
    12 pages
  • Therapy  

  • United Kingdom  

View report >

Therapy Market and Targeted Therapy Market in the UK

  • February 2017
    11 pages
  • Therapy  

    Targeted Therap...  

  • United Kingdom  

    Europe  

View report >

Anesthetics and Therapy Market in the US

  • February 2017
    9 pages
  • Anesthetics  

    Therapy  

  • United States  

View report >

Related Market Segments :

Analgesic

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.